Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Experts from across Europe joined forces to discuss research on substandard and falsified medical products and how to translate the evidence into policy and implementation. Over forty participants from various countries around the world, all based in Europe, including the UK, Sweden, France, Germany and Belgium, joined the in-person informal event at the Richard Doll Building, in Oxford, on the 24th of October.

Group photo of the infomal Medicine Quality meeting, 24 Oct 2024

Hosted by IDDO-MORU-CGHR’s Medicine Quality Research Group (MQRG), participants were mainly from research and public health groups researching substandard and falsified (SF) medical products and advocating for access to quality medicines.

In the morning 14 participants presented their work and the afternoon sessions were dedicated to informal discussions on different themes of interest, such as screening technologies to identify SF medicines (including DEG/EG contaminations in paediatric syrups – visit the The DEG-EG Project pages for more information of the MQRG work on this), the methodology for conducting medicine quality surveys with a focus on conflict areas, and how to raise awareness and engage with various communities around the issues.

Attendees greatly encouraged more such meetings.  One participant said ‘There is a wonderful culture around these meetings’ and another added ‘Delighted to see this wide group continue to build momentum to another conference’.

 

Read the story on the MORU Tropical Health Network website.

Similar stories

KEMRI renews collaboration with Wellcome Trust and University of Oxford

The Kenya Medical Research Institute (KEMRI) has signed a seven-year Memorandum of Agreement with Wellcome Trust, a UK charitable organization, and the University of Oxford, on Wednesday 27 November 2024, at the KEMRI Headquarters, Nairobi. Under this collaboration, Wellcome has awarded GBP 91 million (KES 15 billion) to support research over the next 7 years.